Coagulation markers in diagnostic and monitoring of thromboembolic complication in COVID-19

• Authors: Magdalena Czarnecka-Czapczyńska , Dorota Bartusik-Aebisher , Magdalena Krupka-Olek , David Aebisher , Grzegorz Cieślar , Wojciech Latos , Aleksandra Kawczyk-Krupka

Abstracts

EN

Introduction. Coronavirus disease 2019 (COVID-19) was first observed in China in Wuhan city, Hubei province in December, 2019, and specified as a pandemic by the World Health Organization (WHO). COVID-19 is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV2). Aim. The aim of this article is to discuss epidemiology of thromboembolic complication in COVID-19. Material and methods. This article is a review done in regards to discuss clinical features of the anticoagulation treatment in COVID-19. Analysis of the literature. A review is discussed an anticoagulation treatment in 41 manuscripts. Conclusion. Most commonly coagulation abnormalities in patient with COVID-19 is mild thrombocytopenia. Apart from their typical role in thrombosis and hemostasis, platelets mediate key aspects of immune and inflammatory.

Keywords

EN

anticoagulation; coagulation abnormalities; COVID-19

• Publisher: Uniwersytet Rzeszowski. Wydawnictwo Uniwersytetu Rzeszowskiego
• Journal: European Journal of Clinical and Experimental Medicine
• Year: 2021
• Issue: 3
• Pages: 241-245

Dates

published

2021

Contributors

author

Magdalena Czarnecka-Czapczyńska

• Department of Internal Medicine, Angiology and Physical Medicine, Centre for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Bytom, Poland

author

Dorota Bartusik-Aebisher

• Department of Biochemistry and General Chemistry, Medical College of the University of Rzeszow, University of Rzeszow, Rzeszow, Poland

author

Magdalena Krupka-Olek

• Department of Internal Medicine, Angiology and Physical Medicine, Centre for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Bytom, Poland
• Clinical Department of Internal Medicine, Dermatology and Allergology, Medical University of Silesia, Katowice, Zabrze, Poland

author

David Aebisher

• Department of Biochemistry and General Chemistry, Medical College of the University of Rzeszow, University of Rzeszow, Rzeszow, Poland

author

Grzegorz Cieślar

• Department of Internal Medicine, Angiology and Physical Medicine, Centre for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Bytom, Poland

author

Wojciech Latos

• Department of Internal Medicine, Angiology and Physical Medicine, Centre for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Bytom, Poland

author

Aleksandra Kawczyk-Krupka

• Department of Internal Medicine, Angiology and Physical Medicine, Centre for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Bytom, Poland

Identifiers

DOI

10.15584/ejcem.2021.3.5

Biblioteka Nauki

2040166